MTCR - Metacrine, Inc.

Chart of Metacrine, Inc.(MTCR), Metacrine, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing t

Metacrine, Inc.

MTCR

NASDAQ

Inactive Equity

Metacrine, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapies for patients with gastrointestinal diseases. It is developing MET642, which has completed Phase I clinical trial for the treatment of ulcerative colitis. Metacrine, Inc. was incorporated in 2014 and is headquartered in San Diego, California.

0.581 USD

-0.0076 (-1.31%)

Overview Profile Financial Statements Financial Ratios Chart Analysis News Corporate Actions DCF

Historical Prices

From:

To:

We are unable to load the chart at this time.

FMP

Home Terms of Service Privacy Policy Blog Contact Us

API

Documentation Pricing Formulas Market Indexes

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.